Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease

Volume: 25, Issue: 18, Pages: 2177 - 2187
Published: May 14, 2019
Abstract
The molecular scalpel of clustered regularly interspersed short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) technology may be sharp enough to begin cutting the genes implicated in inflammatory bowel disease (IBD) and consequently decrease the 6.3 billion dollar annual financial healthcare burden in the treatment of IBD. For the past few years CRISPR technology has drastically revolutionized DNA engineering and biomedical...
Paper Details
Title
Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease
Published Date
May 14, 2019
Volume
25
Issue
18
Pages
2177 - 2187
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.